Table 2. Summary of therapy group and control group patient characteristics.

Clinical characteristics	Therapy group	Control group	p-value
Patients (n)	11	11
Age (yr.)			0.023
median (mean)	70 (69)	65 (66)
range	52–76	60–72
Prostate specific antigen (ng/ml)			0.365
median (mean)	18.7 (40.9)	13.8 (17)
range	1.1–260	3.7–34
Gleason score at diagnosis			0.171
6	2 (18%)	1 (9%)
7	5 (46%)	3 (27%)
8	2 (18%)	2 (18%)
9	2 (18%)	4 (37%)
10	0 (0%)	1 (9%)
Clinical stage			0.519
T2c	1 (9%)	5 (45%)
T3a	4 (36%)	0 (0%)
T3b	6 (55%)	6 (55%)